New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

October 24, 2026 Fernanda González

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

Previous Article
The PHP Meltdown Shows How AI Makes Bugs More Exploitable
The PHP Meltdown Shows How AI Makes Bugs More Exploitable

Security researchers used AI tools to help uncover years-old vulnerabilities in the PHP web scripting langu...

Next Article
Best Pet Camera of 2026: Furbo, Petcube, and Enabot
Best Pet Camera of 2026: Furbo, Petcube, and Enabot

Whether you’re near or far, keep an eye on your fur baby with our favorite pet cameras.